Toulouse
France
8
2023-04-13
8
2023-08-22
These are the the leading inventors for applications assigned to INVIVOGEN:
INVIVOGEN based in Toulouse, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction
#2 | 2021-11-18 ✅ Patent 11,730,817 granted on 2023-08-22PRO-CYCLIC DINUCLEOTIDES AND PRO-CYCLIC DINUCLEOTIDE CONJUGATES FOR CYTOKINE INDUCTION
#3 | 2016-12-15 ✅ Patent 10,011,630 granted on 2018-07-03Cyclic dinucleotides for cytokine induction
#4 | 2015-02-05 ✅ Patent 10,705,076 granted on 2020-07-07Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
#5 | 2014-08-28 ✅ Patent 9,295,732 granted on 2016-03-29Conjugated TLR7 and/or TLR8 and TLR2 polycationic agonists
#6 | 2014-05-22 ✅ Patent 9,567,336 granted on 2017-02-14Conjugated TLR7 and/or TLR8 and TLR2 agonists
#7 | 2013-12-19 ✅ Patent 9,458,184 granted on 2016-10-04Compositions of TLR7 and/or TLR8 agonists conjugated to lipids
#8 | 2013-10-31 ✅ Patent 9,637,538 granted on 2017-05-02Anti-HLA monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
Also check out INVIVOGEN's (Toulouse, France) applicant profile with 5 patent applications submitted.
87359 ⎘